Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of more than 1,300 patients in 4 phase II trials.
| Image |  |
|---|---|
| Description | scientific article published on 5 February 2014 |
| Author/s |
author: Robert P Giugliano Dirk J Blom Mats Eriksson Robert Scott |
| Publication date | February 5, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |